{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:24:33Z","timestamp":1790601873761,"version":"4.1.0"},"reference-count":10,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"MRC\/NIHR Better Methods Better Research funding","award":["MR\/X011461\/1"],"award-info":[{"award-number":["MR\/X011461\/1"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Psychotherapy Research"],"DOI":"10.1080\/10503307.2026.2721641","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:46:59Z","timestamp":1789170419000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Non-inferiority margins for trials need to be meaningful: commentary on Fl\u00fcckiger et al. (2026)"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-1870","authenticated-orcid":false,"given":"Jan R.","family":"Boehnke","sequence":"first","affiliation":[{"name":"University of Dundee","place":["Dundee, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-7183","authenticated-orcid":false,"given":"Beatriz","family":"Goul\u00e3o","sequence":"additional","affiliation":[{"name":"School of Health & Wellbeing, University of Glasgow","place":["Glasgow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330232"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068135"},{"key":"e_1_3_2_4_1","volume-title":"Guideline on non-inferiority and equivalence comparisons in clinical trials\u2014draft agreed by the methodology working party (EMA\/301654\/2025)","author":"European Medicines Agency","year":"2025","unstructured":"European Medicines Agency. (2025). Guideline on non-inferiority and equivalence comparisons in clinical trials\u2014draft agreed by the methodology working party (EMA\/301654\/2025)."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/10503307.2026.2653992"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0024338"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05451-x"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.6390563"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1525\/collabra.33267"},{"key":"e_1_3_2_10_1","volume-title":"Non-Inferiority clinical trials to establish effectiveness: Guidance for industry","author":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), & Center for Biologics Evaluation and Research (CBER)","year":"2016","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), & Center for Biologics Evaluation and Research (CBER). (2016). Non-Inferiority clinical trials to establish effectiveness: Guidance for industry. Food and Drug Administration."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003896"}],"container-title":["Psychotherapy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10503307.2026.2721641","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10503307.2026.2721641","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10503307.2026.2721641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:47:00Z","timestamp":1789170420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10503307.2026.2721641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":10,"alternative-id":["10.1080\/10503307.2026.2721641"],"URL":"https:\/\/doi.org\/10.1080\/10503307.2026.2721641","relation":{},"ISSN":["1050-3307","1468-4381"],"issn-type":[{"value":"1050-3307","type":"print"},{"value":"1468-4381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tpsr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tpsr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}